Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.32	112.37	109.82
Graham Fair Price	3.74	53.32	51.40
PEG	-86.25	2.45	-17.82
Price/Book	36.43	39.93	29.27
Price/Cash Flow	64.35	744.44	-452.96
Prices/Earnings	9.47	38.86	35.50
Price/Sales	27.63	60.43	47.35
Price/FCF	64.35	744.44	-452.96
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.04	0.85	0.85
Operating Margin	22.05	0.50	0.41
ROA	21.70	0.08	0.07
ROE	0.21	0.26	24.63
ROIC	0.16	0.21	28.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-83.66
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	< 0.005	0.21	3763.28
EPS QOQ	-0.02	0.16	695.85
FCF QOQ	-1.23	1.77	44.31
Revenue QOQ	0.12	< 0.005	-93.57
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	285.90	304.96	6.67
Days Sales Outstanding (DSO)	102.84	86.91	-15.49
Inventory Turnover	0.31	0.30	-6.25
Debt/Capitalization	0.20	0.21	5.83
Quick Ratio	0.62	0.44	-29.68
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23.87	22.18	-7.07
Cash	6.77	2.09	-69.19
Capex	-3.68	-2.02	45.12
Free Cash Flow	-1.54	1.19	-22.86
Revenue	14.75	14.65	-0.67
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.82	0.70	-14.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.44	0.58	31.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating